MNKD Financials | Key Metrics & Investor Analysis

The financial statements for MNKD (MNKD) provide a snapshot of revenue trends, balance-sheet strength, and cash flow quality. Reviewing these together helps investors evaluate earnings durability, capital structure, and whether operating cash flow supports long-term business growth.

See stock fair value and complete historical financials—premium unlocks deeper tables and metrics.

Financial Statements

Related peers

Compare More →
A
Agilent Technologies, Inc.
$119.77
-0.51%
VERA
Vera Therapeutics, Inc.
$43.45
-2.05%
HRMY
Harmony Biosciences Holdings, Inc.
$29.22
-0.24%
BHVN
Biohaven Ltd.
$10.37
-0.67%
NUVB
Nuvation Bio Inc.
$4.82
-0.72%
D
Dominion Energy, Inc.
$62.38
-2.09%

Frequently Asked Questions

What are MNKD's latest financial results?

Review MNKD's latest balance sheet, income statement, and cash flow to understand its profitability, revenue trends, and financial health. These metrics are essential for evaluating short-term performance and long-term stability.

How has MNKD's revenue and net income changed over time?

Analyzing historical revenue and net income shows growth trends and business performance. Consistent growth indicates operational strength, while declines may signal challenges that investors should consider.

What is MNKD's cash flow situation and liquidity?

Cash flow statements reveal how MNKD generates and uses cash. Strong operating cash flow and sufficient liquidity suggest the company can fund operations, pay dividends, and handle debt effectively.

How does MNKD's financial performance compare to industry peers?

Comparing key metrics like revenue growth, profit margins, and debt levels with competitors helps investors assess whether MNKD is outperforming or lagging within its sector.

Are MNKD's financial statements showing sustainable profitability?

By analyzing margins, ROE, ROIC, and cash generation over multiple periods, investors can evaluate whether MNKD's profits are repeatable and supported by strong fundamentals.